Cardiovascular outcomes associated with treatment of type 2 diabetes in patients with ischaemic heart failure.

Thomas R GodecDaniel I BromageMar Pujades-RodriguezAntonio CannatàArturo Gonzalez-IzquierdoSpiros DenaxasHarry HemingwayAjay M ShahDerek M YellonTheresa A McDonagh

Published in: ESC heart failure (2022)

When considering changes in antidiabetic treatment over time, all drug classes were associated with reduced risk of cardiovascular mortality and HF hospitalization.

Keyphrases

type diabetes
heart failure
cardiovascular disease
cardiovascular events
risk factors
combination therapy
adipose tissue
atrial fibrillation
coronary artery disease
electronic health record
adverse drug